More than three years on from the release of the roadmap for integrating specialised services within integrated care systems (ICSs), and with 70 specialised services now delegated, the future of specialised commissioning is still up in the air.
The impending abolition of NHS England and consolidation of ICSs has necessitated a rethink within NHSE’s transition leadership team and the Department of Health and Social Care (DHSC). Indeed, in Sir Jim Mackey’s first interview as interim CEO he signalled a potential change in direction, stating “the right level of commissioning for different specialised services would have to be reconsidered”.
Sir Jim’s attention on specialised commissioning is no surprise given his experience running Newcastle Hospitals Foundation Trust, one of the most financially stable Trusts in the country which draws around two thirds of its income from specialised commissioning.
Three months later, and ahead of any formal announcements, here’s what we might expect:
1. Local responsibilities
A key concern with the delegation of specialised services has been the capacity of individual ICBs to take on additional commissioning responsibilities. To overcome this, ICBs are likely to group together on a regional basis, allowing them to commission on a pan-ICB basis, supporting commissioning and population management at scale.
To ensure this approach is truly joined up, we expect to see the emergence of an ‘Office for Pan ICB Commissioning’, hosted by a lead ICB, but supporting the whole region.
It’s unclear what criteria might be used to decide on these lead ICBs, but they are likely to be those closely aligned to Foundation Trusts where skillsets exist.
2. What will be commissioned and where?
With a new structure in place, ICBs will be expected to quickly determine which services they want to commission individually vs collectively through pan-ICB commissioning. While they will have the autonomy to do this, their decisions are likely to be sense checked by NHS regions.
Regions are unlikely to veto any decisions but will play an important role in ensuring a standardised approach, making ICBs pool budgets and adhere to service specifications.
Nationally, an Office for Specialised Commissioning is likely to be established in the DHSC. This will commission highly specialised services and set national standards. While it is possible that the DHSC will claw back commissioning responsibility for some already delegated services, this new arrangement is unlikely to result in a full reversal of specialised commissioning delegation – especially as it is widely accepted that some specialised services are not, in practice, particularly specialised as a whole or in part.
3. How can these changes be implemented successfully?
As with much of recent NHS policy development, these changes may sound familiar to those who have been around for a while. For Offices for Pan ICB Commissioning – see Strategic Health Authorities (SHAs), abolished in 2013, they provided strategic direction and performance management at a regional level with some leading on specific Specialised commissioning across large populations via centralised expert teams of commissioners, finance staff and pharmacists.
SHAs were largely successful and learnings from their success should be used to implement the future of specialised commissioning. Other key considerations for ICBs and the DHSC are:
While the road to delegating Specialised Services has been rocky, the clear direction coming down the line provides the certainty and frameworks required to provide specialist care for all. It’s now up to the DHSC, in their position of power, to provide stronger foundations to make a success of the new model.